Please check your internet connection and try again.
# Meftal spas
## Overview
Meftal spas is a combination product containing mefenamic acid (a nonsteroidal anti-inflammatory drug, NSAID) and hyoscine butylbromide (an anticholinergic antispasmodic).
## Primary Indications
* Symptomatic relief of painful conditions, particularly those associated with smooth muscle spasm, such as abdominal cramps, dysmenorrhea, and irritable bowel syndrome.
* Pain and inflammation associated with musculoskeletal conditions.
## Adult Dosing
* **Meftal spas tablets:** Typically 1 tablet (containing mefenamic acid 250 mg and hyoscine butylbromide 10 mg) three times daily.
* **Maximum daily dose:** Not explicitly defined for the combination, but individual component maximums should be considered. Mefenamic acid: typically 750 mg every 8 hours or 1500 mg daily. Hyoscine butylbromide: typically 20 mg three times daily.
## Pediatric Dosing
* Use in pediatric patients is generally not recommended due to limited data and potential risks associated with both components. Specific pediatric dosing is not established.
## Dose Adjustments
* **Renal Impairment:** Mefenamic acid should be used with caution in patients with severe renal impairment. Dose reduction may be necessary based on individual response and renal function.
* **Hepatic Impairment:** Mefenamic acid should be used with caution in patients with hepatic impairment. Dose reduction may be necessary based on individual response and liver function.
* **Elderly:** Elderly patients may be at increased risk of adverse effects from NSAIDs, including gastrointestinal bleeding and renal toxicity. Use with caution and consider lower doses.
## Contraindications
* Hypersensitivity to mefenamic acid, hyoscine butylbromide, or any excipients.
* Active or history of recurrent peptic ulceration or gastrointestinal bleeding.
* Severe renal or hepatic impairment.
* Severe heart failure.
* History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Prostatic hypertrophy.
* Tachycardia, glaucoma, paralytic ileus, intestinal obstruction, atony of the bowel.
* Pregnancy (especially third trimester) and breastfeeding.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, dyspepsia, abdominal pain, constipation, gastrointestinal bleeding, ulceration.
* **Central Nervous System:** Dizziness, headache, drowsiness.
* **Anticholinergic:** Dry mouth, blurred vision, urinary retention, constipation, tachycardia.
* **Other:** Rash, pruritus, tinnitus, fluid retention, edema, increased blood pressure. Severe allergic reactions (anaphylaxis), bronchospasm, Stevens-Johnson syndrome, toxic epidermal necrolysis.
## Key Drug Interactions
* **NSAIDs:** Increased risk of gastrointestinal bleeding with concomitant use of other NSAIDs, corticosteroids, aspirin, or anticoagulants.
* **Anticoagulants/Antiplatelets:** Increased risk of bleeding.
* **ACE Inhibitors/ARBs/Diuretics:** NSAIDs can reduce the efficacy of antihypertensives and diuretics and may increase the risk of nephrotoxicity.
* **Lithium:** NSAIDs can increase serum lithium levels.
* **Methotrexate:** NSAIDs can increase methotrexate toxicity.
* **Potassium-Sparing Diuretics:** Increased risk of hyperkalemia.
* **Other Anticholinergics:** Additive anticholinergic effects.
* **Dopamine Antagonists:** May reduce the gastrointestinal prokinetic effects of dopamine antagonists.
* **Amantadine:** Increased anticholinergic effects.
* **Tricyclic Antidepressants/MAOIs:** Increased anticholinergic effects.
* **Antihistamines:** Increased anticholinergic effects.
* **Proton Pump Inhibitors:** May mask GI symptoms.
## Monitoring
* **Gastrointestinal:** Monitor for signs and symptoms of GI bleeding and ulceration (e.g., melena, hematemesis).
* **Renal Function:** Monitor renal function, especially in patients with pre-existing renal disease or those at risk.
* **Hepatic Function:** Monitor liver function, particularly with long-term use or in patients with hepatic impairment.
* **Blood Pressure:** Monitor blood pressure, especially in patients with hypertension.
* **Hydration:** Monitor for signs of dehydration with anticholinergic effects.
## Clinical Pearls
* Meftal spas should be taken with food or milk to minimize gastrointestinal upset.
* Due to the anticholinergic effects, caution should be exercised in the elderly and in patients with conditions exacerbated by anticholinergics (e.g., glaucoma, prostatic hypertrophy).
* The risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke associated with NSAIDs may increase with duration of use and in patients with risk factors.
* Discontinue Meftal spas immediately if signs of gastrointestinal bleeding, skin rash, or hypersensitivity occur.
This information is intended for healthcare professionals and should not substitute for professional medical advice. Always refer to the most current prescribing information and consult with a qualified healthcare provider for any medical condition or treatment.
